Clinical Outcomes Following PM Implantation: A 3-Year Comparative Study of Sick Sinus Syndrome and Atrioventricular

Fuat Polat1,2, Haşim Tüner3, Veysi Can4

  • 1Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Education Research Hospital, Istanbul - Turquia.

Insights

Permanent pacemaker implantation offers similar symptom relief for sick sinus syndrome (SSS) and atrioventricular block (AVB). However, distinct cardiac remodeling patterns and mortality predictors necessitate etiology-specific follow-up strategies for pacemaker recipients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Imaging

Background:

  • Permanent pacemaker implantation is a standard treatment for sick sinus syndrome (SSS) and atrioventricular block (AVB).
  • Limited comparative data exist on long-term outcomes and cardiac remodeling between SSS and AVB after pacemaker implantation.

Purpose of the Study:

  • To compare three-year clinical outcomes and cardiac structural changes in patients with SSS versus AVB post-pacemaker implantation.
  • To identify distinct cardiac remodeling patterns and mortality predictors based on bradyarrhythmic etiology.

Main Methods:

  • Retrospective observational study of 192 adult patients (65 SSS, 127 AVB) undergoing pacemaker implantation.
  • Assessment of demographic, echocardiographic, pacemaker, and clinical data at baseline and up to three years.
  • Primary outcomes included cardiac structure/function changes, symptomatic improvement, atrial fibrillation, rehospitalization, and mortality.

Main Results:

  • Both SSS and AVB groups showed similar declines in left ventricular ejection fraction over three years.
  • SSS patients exhibited significant left atrial and ventricular dilation with increased mitral regurgitation.
  • AVB patients maintained stable chamber dimensions despite high ventricular pacing; mortality predictors differed between groups.

Conclusions:

  • Sick sinus syndrome and atrioventricular block patients experience comparable symptomatic benefits and clinical outcomes after pacemaker implantation.
  • Distinct cardiac remodeling patterns and differing mortality predictors underscore the need for etiology-specific follow-up strategies.
  • Etiology-specific management may optimize long-term care for individuals with bradyarrhythmias requiring pacemakers.
Abstract

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...